Gain Therapeutics
Gain Therapeutics is a preclinical stage biotech company.
Gain Therapeutics has raised €2.5M across 1 funding round from 3 investors, most recently a Series A round in Jan 2019. Based in Lugano, Switzerland; founded 2017; active in Fintech. Data as of 28 Oct 2026.
Total raised
€2.5M
€2,500,000
Funding rounds
1
Investors
3
distinct backers
Active since
2019-01
latest 2019-01
Funding by year
EUR raised per yearGain Therapeutics — funding by year — interactive chart.
Data table
| Gain Therapeutics — funding by year | |
|---|---|
| 2018 | €2.5M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Series A | €2.5M | Helsinn Investment Fund,TriVentures,VitaTech S.A | View deal → |